A traditional Chinese medicine composition for treating oral mucositis

By applying a traditional Chinese medicine patch composed of Evodia rutaecarpa, cinnamon, Asarum sieboldii, and cloves to the Yongquan acupoint, the treatment of oral mucositis caused by chemotherapy has been solved, achieving the effect of effectively relieving pain and reducing oral inflammation.

CN118593584BActive Publication Date: 2026-11-17ZHEJIANG CANCER HOSPITAL
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202410674308.8
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-05-28
Publication Date
2026-11-17
Estimated Expiration
2044-05-28

AI Technical Summary

Technical Problem

There is a lack of effective traditional Chinese medicine compositions for treating oral mucositis caused by chemotherapy in the current technology, and single traditional Chinese medicine patches are difficult to achieve satisfactory results. Oral mucositis caused by chemotherapy drugs has complex syndromes, and existing symptomatic treatments are not effective.

Method used

A traditional Chinese medicine composition with Evodia rutaecarpa, cinnamon, Asarum sieboldii, and clove as the main ingredients is made into a patch or ointment. It is applied to the Yongquan acupoint to nourish kidney yin, guide fire back to its source, and relieve oral ulcers caused by deficiency fire due to liver and kidney yin deficiency and heart-kidney disharmony.

Benefits of technology

It significantly reduces the incidence of oral mucositis caused by chemotherapy, alleviates patient pain, improves quality of life, is simple to operate, has high safety, and has significant clinical therapeutic effects.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004863584740000061
    Figure BDA0004863584740000061
  • Figure BDA0004863584740000062
    Figure BDA0004863584740000062
  • Figure BDA0004863584740000071
    Figure BDA0004863584740000071
Patent Text Reader

Abstract

This invention relates to a traditional Chinese medicine composition for treating chemotherapy-induced oral mucositis. The composition is made from 5 parts by weight of Evodia rutaecarpa, 1 part by weight of Cinnamomum cassia, 1 part by weight of Asarum heterotropoides, and 1 part by weight of Clove. The preparation method of this traditional Chinese medicine composition is simple, and it is convenient to administer by applying it to the Yongquan acupoint during treatment. It is highly safe and can play an important clinical therapeutic role in the treatment of chemotherapy-induced oral mucositis.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of traditional Chinese medicine, specifically to a traditional Chinese medicine composition for treating oral mucositis caused by chemotherapy. Background Technology

[0002] Oral mucositis is an inflammatory condition of the oral mucosa caused by various factors, including oral candidiasis (also known as thrush), lichen planus, membranous stomatitis, and allergic stomatitis. It is mainly characterized by erosion and ulceration of the oral mucosa, often with recurrent small ulcers, commonly occurring on the lips, the proximal border of the tongue, the tip of the tongue, and the buccal mucosa. The causes of oral mucositis are complex and related to factors such as vitamin B2 deficiency, bacterial infection, systemic diseases, and indigestion. Oral mucositis has a significant impact on patients' lives, increasing the risk of malnutrition due to difficulty eating, and increasing negative psychological factors such as resistance to treatment, seriously affecting the patient's prognosis.

[0003] There is no standardized treatment plan for oral mucositis in clinical practice. Currently, treatment mainly focuses on symptomatic and supportive care, including strengthening oral hygiene, maintaining good oral hygiene, avoiding hot, highly acidic, and spicy foods, increasing dietary nutrition, and taking symptomatic pain relief medications such as lidocaine, morphine, and oxycodone. Although these routine symptomatic treatments can alleviate the patient's symptoms to some extent, the treatment effect is still not ideal.

[0004] Oral mucositis falls under the category of "oral erosion" in Traditional Chinese Medicine (TCM), and its treatment primarily focuses on clearing heat and detoxifying, replenishing qi and promoting fluid production. TCM classifies oral mucositis into two types based on clinical symptoms: damp-heat accumulation syndrome and yin deficiency with fire excess syndrome. The former is clinically characterized by extensive oral erosions with white, necrotic material, redness, swelling, pain, dry mouth, halitosis, abdominal distension, poor appetite, dark yellow urine, a red tongue with a yellow, greasy coating, and is treated with heat-clearing, dampness-removing, detoxifying, and necrotic material-removing medications. The latter is clinically characterized by oral and lingual erosions or ulcers, recurrent episodes, irritability, hot flashes, a tender red tongue with little coating, and is treated with yin-nourishing and fire-reducing medications.

[0005] Chemotherapy-induced oral mucositis is caused by the prolonged exposure to chemotherapy drugs. Patients with this condition often have a weak constitution, and their oral ulcers are frequently due to upward flaring of deficient heat. Although the ulcers are located in the oral cavity, they are closely related to the heart, liver, spleen, and kidneys. For example, the heart is the root of the tongue, and upward flaring of heart fire can cause ulcers on the tip of the tongue. The Foot Taiyin Spleen Meridian runs along the root of the tongue and disperses under the tongue; a branch of the Foot Jueyin Liver Meridian runs from the "eye system" down to the cheek and encircles the inner lip; the Foot Shaoyin Kidney Meridian runs along the throat and flanks the root of the tongue. Dysfunction of these organs can all lead to oral mucositis. Therefore, the syndrome of chemotherapy-induced oral mucositis is not limited to the two types mentioned above. Many patients may exhibit symptoms such as damp-heat in the spleen and stomach, or deficiency of both the heart and spleen. Simply using a single Chinese herbal plaster often fails to achieve satisfactory results.

[0006] The *Ling Shu* (Spiritual Pivot), Chapter 2, states: "The kidney originates from Yongquan (Kidney 1), which is the center of the foot, and is a well-shaped point associated with wood." The Yongquan acupoint on the sole of the foot is associated with the generation of water by Heaven. Originating in the center of the foot, it resembles a spring gushing forth from the ground, hence its name. This acupoint is of the nature of cold water, belonging to the wood element in the Five Elements theory. Water nourishes wood; if kidney water is insufficient, it easily leads to insufficient liver yin, further causing liver and kidney yin deficiency, upward flaring of deficient fire, and even excessive yang generating wind. Therefore, this acupoint, being of cold water, can nourish kidney yin. Applying warming medicinal patches to this acupoint can nourish kidney water and guide fire back to its source.

[0007] Currently, there are few reports on traditional Chinese medicine formulas that are effective in treating oral mucositis caused by chemotherapy. Therefore, further exploring drugs from the field of traditional Chinese medicine that can be used to treat oral mucositis caused by chemotherapy and have low side effects has become an urgent technical problem to be solved. Summary of the Invention

[0008] To solve the above-mentioned technical problems, the present invention includes the following aspects:

[0009] A first aspect of the present invention provides a traditional Chinese medicine composition for treating oral mucositis caused by chemotherapy, the traditional Chinese medicine composition being made from Evodia rutaecarpa, cinnamon, Asarum heterotropoides and clove.

[0010] Preferably, the traditional Chinese medicine composition is made from 2-8 parts by weight of Evodia rutaecarpa, 1-5 parts by weight of Cinnamomum cassia, 1-5 parts by weight of Asarum heterotropoides and 1-5 parts by weight of Clove.

[0011] More preferably, the traditional Chinese medicine composition is made from 4-6 parts by weight of Evodia rutaecarpa, 1-3 parts by weight of Cinnamomum cassia, 1-3 parts by weight of Asarum heterotropoides and 1-3 parts by weight of Clove.

[0012] Most preferably, the traditional Chinese medicine composition is made from 5 parts by weight of Evodia rutaecarpa, 1 part by weight of Cinnamomum cassia, 1 part by weight of Asarum heterotropoides and 1 part by weight of Clove.

[0013] Preferably, the traditional Chinese medicine composition further includes pharmaceutically acceptable excipients.

[0014] Preferably, the traditional Chinese medicine composition is a topical preparation.

[0015] Preferably, the dosage form of the traditional Chinese medicine composition is a patch or ointment.

[0016] More preferably, the dosage form of the traditional Chinese medicine composition is a patch.

[0017] Preferably, the preparation method of the traditional Chinese medicine composition includes the following steps: take the prescribed amount of Evodia rutaecarpa, cinnamon, Asarum heterotropoides and cloves, pulverize and mix them, add an appropriate amount of vinegar, mix into a paste, roll into small pills, and place them in a spunlace breathable adhesive patch to obtain the product.

[0018] Preferably, the dimensions are 7 cm * 7 cm.

[0019] Preferably, the oral mucositis caused by chemotherapy is oral mucositis caused by doxorubicin.

[0020] More preferably, the oral mucositis caused by chemotherapy is oral mucositis caused by liposomal doxorubicin.

[0021] A second aspect of the present invention provides a method for preparing the above-mentioned traditional Chinese medicine composition, comprising the following steps:

[0022] Take the prescribed amounts of Evodia rutaecarpa, cinnamon, Asarum heterotropoides, and cloves, grind them into powder, mix them well, add an appropriate amount of vinegar, make a paste, roll it into small pills, and place them in a spunlace breathable adhesive patch.

[0023] Preferably, the dimensions are 7 cm * 7 cm.

[0024] A third aspect of the present invention provides the use of the above-mentioned traditional Chinese medicine composition in the preparation of a medicament for the prevention or treatment of oral mucositis.

[0025] Preferably, the oral mucositis is oral mucositis caused by chemotherapy.

[0026] More preferably, the oral mucositis is oral mucositis caused by doxorubicin.

[0027] More preferably, the oral mucositis is oral mucositis caused by liposomal doxorubicin.

[0028] This invention relates to a traditional Chinese medicine patch based on vinegar-mixed Evodia rutaecarpa powder, with the addition of cinnamon, asarum, and clove powder. Evodia rutaecarpa is pungent, hot, and drying, entering the liver and kidney meridians. It dispels cold and relieves pain, treating oral ulcers caused by deficiency-heat due to liver and kidney yin deficiency and heart-kidney disharmony, effectively alleviating pain in patients with oral mucositis. Cinnamon is pungent, sweet, and very hot, entering the kidney, spleen, heart, and liver meridians. When applied to the Yongquan acupoint, the two herbs together can draw downwards the deficiency-heat from various organs, serving as the main herbs for guiding fire back to its source. Asarum is warm in nature, entering the heart, lung, and kidney meridians, acting as a guiding herb for the kidney meridian. Applying it to the Yongquan acupoint strengthens the downward flow of deficiency-heat from the kidney meridian. Clove is also warm in nature, primarily entering the spleen and stomach meridians. It warms the middle jiao, descends rebellious qi, promotes qi circulation, and relieves pain, treating oral ulcers caused by deficiency-heat in the spleen and stomach.

[0029] The technical effects of this invention are as follows:

[0030] 1. The traditional Chinese medicine composition of the present invention has a reasonable compatibility. The inventors optimized the components and content ratio of the traditional Chinese medicine through experiments, and selected the traditional Chinese medicine composition with the best therapeutic effect from many prescriptions (Example 1). The traditional Chinese medicine composition of the present invention has a simple preparation method, high safety, and can play an important clinical therapeutic role in the field of chemotherapy-induced oral mucositis.

[0031] 2. When using the herbal patch of this invention, it is applied to the Yongquan acupoint to draw fire downward. It is simple to operate and has advantages such as being economical and non-invasive, making it acceptable to patients and medical staff. Detailed Implementation

[0032] The present invention will be further described below with reference to embodiments, but the implementation of the present invention is not limited thereto. Unless otherwise specified, the experimental methods used in the following embodiments are conventional methods.

[0033] Example 1

[0034] Take 10g of Evodia rutaecarpa, 2g of Cinnamomum cassia, 2g of Asarum heterotropoides and 2g of Clove, grind them into powder and mix them evenly. Add an appropriate amount of vinegar and mix into a paste. Roll the paste into 10 small pills and place each pill in a 7cm*7cm spunlace breathable adhesive patch to obtain the herbal patch 1 of this invention.

[0035] Example 2

[0036] Take 4g of Evodia rutaecarpa, 4g of Cinnamomum cassia, 4g of Asarum heterotropoides and 4g of Clove, grind them into powder and mix them evenly. Add an appropriate amount of vinegar to make a paste, roll it into 10 small pills, and place each small pill in a 7cm*7cm spunlace breathable adhesive patch to obtain the herbal patch 2 of this invention.

[0037] Example 3

[0038] Take 13g of Evodia rutaecarpa, 1g of Cinnamomum cassia, 1g of Asarum heterotropoides and 1g of Clove, grind them into powder and mix them evenly. Add an appropriate amount of vinegar to make a paste, roll it into 10 small pills, and place each small pill in a 7cm*7cm spunlace breathable adhesive patch to obtain the herbal patch 3 of this invention.

[0039] Example 4

[0040] Take 4g of Evodia rutaecarpa, 8g of Cinnamomum cassia, 2g of Asarum heterotropoides and 2g of Clove, grind them into powder and mix them evenly. Add an appropriate amount of vinegar and mix into a paste. Roll the paste into 10 small pills and place each pill in a 7cm*7cm spunlace breathable adhesive patch to obtain the herbal patch 4 of this invention.

[0041] Example 5

[0042] Take 4g of Evodia rutaecarpa, 2g of Cinnamomum cassia, 8g of Asarum heterotropoides and 2g of Clove, grind them into powder and mix them evenly. Add an appropriate amount of vinegar to make a paste, roll it into 10 small pills, and place each small pill in a 7cm*7cm spunlace breathable adhesive patch to obtain the herbal patch of the present invention 5.

[0043] Example 6

[0044] Take 4g of Evodia rutaecarpa, 2g of Cinnamomum cassia, 2g of Asarum heterotropoides and 8g of Clove, grind them into powder and mix them evenly. Add an appropriate amount of vinegar and mix into a paste. Roll the paste into 10 small pills and place each pill in a 7cm*7cm spunlace breathable adhesive patch to obtain the herbal patch 6 of this invention.

[0045] Example 1: Clinical trial of the herbal patch of the present invention for treating oral mucositis caused by liposomal doxorubicin.

[0046] 1. Test Methods

[0047] 1.1 Research Subjects

[0048] Sixty-seven patients receiving liposomal doxorubicin chemotherapy at a tertiary oncology hospital in Zhejiang Province from May 2023 to April 2024 were randomly selected as the study subjects. They were randomly divided into a control group (n=34) and a drug group (n=33). Both groups consisted of females. The average age in the control group was 49.29±11.27 years, while the average age in the drug group was 52.03±11.49 years. In the control group, 15 patients had a history of oral ulcers, and 19 had no history of oral ulcers. In the drug group, 22 patients had a history of oral ulcers, and 11 had no history of oral ulcers. The differences in general characteristics between the two groups were statistically significant (P<0.05). All patients signed informed consent forms, and this study has been reviewed and approved by the hospital's ethics committee.

[0049] 1.2 Diagnostic and Inclusion Criteria

[0050] 1.2.1 Diagnostic Criteria

[0051] Referencing the diagnostic points for chemotherapy-induced oral mucositis in *Practical Stomatology*, edited by Zhang Zhenkang and published by People's Medical Publishing House:

[0052] ① The patient had a history of chemotherapy within 21 days prior to the onset of the disease;

[0053] ② Occurs on the mucous membranes of the oral cavity, including the lips, floor of the mouth, tongue margins, cheeks, palate, and oropharynx;

[0054] ③ Clinical manifestations include erythema and peeling of the oral mucosa, edema and erosion of the oral mucosa, formation of white membrane, ulceration, surrounding edema, bleeding, oozing, redness, swelling and pain, and pain aggravated when eating.

[0055] 1.2.2 Inclusion Criteria

[0056] Patients must meet the diagnostic criteria for chemotherapy-induced oral mucositis; be pathologically confirmed to have primary breast cancer; be breast cancer patients receiving liposomal doxorubicin chemotherapy; have no intellectual or mental impairments, be able to communicate normally, and be able to cooperate in assessing pain and quality of life; be older than 18 years; and be willing to participate in this study.

[0057] 1.2.3 Exclusion Criteria

[0058] Patients with diseases that have been proven to cause oral mucosal erythema and / or scarring, such as Behcet's disease, herpetic stomatitis, and recurrent necrotizing mucositis, or those with oral mucositis caused by reasons other than chemotherapy; patients with organic diseases of the heart, liver, kidneys, etc., and severe bone marrow suppression who cannot complete the original chemotherapy plan; and patients who cannot complete the original chemotherapy regimen for various reasons.

[0059] 1.3 Administration Method

[0060] Control group: Patients received standard oral care, following the guidelines for prevention and care of oral mucositis related to radiotherapy and chemotherapy (Chinese Nursing Association Group Standard). This included instructing patients on daily oral hygiene, brushing teeth morning and night, rinsing after meals, and maintaining cleanliness of teeth, gums, tongue, and mucous membranes. Daily assessments of oral mucosal condition were conducted. Patients with oral mucositis were given Kangfuxin solution as a mouthwash: 10ml each time, four times daily (once after meals and once before bedtime, rinsing for 5-10 minutes each time), until the oral mucosa healed. This solution was not used by patients without oral mucositis.

[0061] The drug group of this invention: While performing routine oral care, starting at 18:00 on the evening of chemotherapy, apply the traditional Chinese medicine patch 1 prepared in Example 1 of this invention to the Yongquan acupoint (the depression at the front 1 / 3 of the sole of the foot), and remove it at 9:00 the next morning. Use continuously for 4 days. If oral mucositis occurs, continue applying the patch until the oral mucosa heals.

[0062] 1.4 Evaluation Indicators

[0063] 1.4.1 Incidence of Chemotherapy-Induced Oral Mucositis

[0064] The diagnostic criteria for chemotherapy-induced oral mucositis are the same as those in Section 1.2 of this study.

[0065] 1.4.2 Oral Health Scale Scoring

[0066] The Oral Gland Appearance Scale (OAG) originated from Eliers et al. The scale consists of 8 items, including voice, swallowing, lips, tongue, saliva, mucous membranes, gums, and teeth. Each item is scored from 1 to 3, with 1 point for normal, 2 points for moderate impairment, and 3 points for severe impairment.

[0067] 1.4.3 Pain score

[0068] The numerical pain rating scale was used, and patients scored their oral pain complaints on a scale of 1 to 10. 0 points indicated no pain, 10 points indicated the most painful, 1-3 points indicated mild pain, 4-6 points indicated moderate pain, and 6-10 points indicated severe pain.

[0069] 1.5 Quality Control

[0070] Before the trial began, relevant personnel underwent standardized training. A dedicated person within the research team was responsible for coordinating the entire research process, regularly publishing progress reports, and resolving any issues that arose. A designated person managed the data, periodically checked the data, and promptly identified any problems. Operators received standardized training on acupoint application according to the "Handbook for the Use of Traditional Chinese Medicine Techniques by Nursing Staff," and only those who passed the assessment were allowed to perform the procedures. An oral mucositis database was constructed: EpiData 3.0 was used to create the database, employing a dual-person, dual-input method for data entry. Logical verification of the data was performed, and any errors were immediately corrected using a self-made scale to ensure data integrity and accuracy. Once the data was verified to be correct, it was locked.

[0071] 1.6 Statistical Analysis

[0072] Data were processed using SPSS 22.0 statistical software. Quantitative data were expressed as mean ± standard deviation, and t-tests were used for comparisons between groups. Categorical data were described as percentages, and χ² tests were used for comparisons between groups. 2 The significance level was set at α = 0.05, and p < 0.05 was considered statistically significant.

[0073] 2. Test Results

[0074] 2.1 Comparison of the incidence of oral mucositis among patients

[0075] As shown in Table 1, the number of cases of oral mucositis in the drug group of the present invention was much lower than that in the control group, and the difference was statistically significant (P<0.05).

[0076] Table 1 Comparison of the incidence of oral mucositis in the two experimental groups

[0077]

[0078] 2.2 Comparison of patients' oral conditions

[0079] As shown in Table 2, the oral condition scale (OAG scale) score of the drug group of the present invention was lower than that of the control group, and the difference was statistically significant (P<0.05).

[0080] Table 2 Comparison of oral health scores between the two experimental groups

[0081]

[0082]

[0083] 2.3 Comparison of Patient Pain Scores

[0084] As shown in Table 3, the pain score of the drug group of the present invention was lower than that of the control group, and the difference was statistically significant (P<0.05).

[0085] Table 3 Comparison of pain scores between the two experimental groups

[0086]

[0087] The above experimental results show that, compared with the control group, the incidence of oral mucositis in the drug group of the present invention was significantly reduced, and the oral condition score and pain score were significantly reduced, confirming that the traditional Chinese medicine patch of the present invention has a significant preventive and therapeutic effect on oral mucositis caused by chemotherapy.

[0088] Although specific embodiments of the invention have been described, those skilled in the art will recognize that various changes and modifications can be made to the invention without departing from its scope or spirit. Therefore, the invention is intended to cover all such changes and modifications falling within the scope of the appended claims and their equivalents.

Claims

1. The use of a traditional Chinese medicine composition in the preparation of a drug for the prevention or treatment of oral mucositis caused by liposomal doxorubicin, characterized in that, The traditional Chinese medicine composition is made from 5 parts by weight of Evodia rutaecarpa, 1 part by weight of Cinnamomum cassia, 1 part by weight of Asarum heterotropoides and 1 part by weight of Clove. The traditional Chinese medicine composition is a topical preparation.

2. The application according to claim 1, characterized in that, The traditional Chinese medicine composition further includes pharmaceutically acceptable excipients.

3. The application according to claim 1, characterized in that, The dosage form of the traditional Chinese medicine composition is a patch.

4. The application according to any one of claims 1-3, characterized in that, The preparation method of the pharmaceutical composition includes the following steps: take the prescribed amount of Evodia rutaecarpa, cinnamon, Asarum sieboldii and clove, pulverize and mix them, add an appropriate amount of vinegar, mix into a paste, roll into small pills, and place them in a spunlace breathable adhesive patch to obtain the pharmaceutical composition.

Citation Information

Patent Citations

  • Oral ulcer acupoint patch and production process thereof

    CN111467401A